[1] Dryden MS.Skin and soft tissue infection: microbiology and epidemiology[J]. Int J Antimicrob Agents, 2009, 34Suppl1:S2-S7. [2] Stevens DL, Bisno AL, Chambers HF, et al.Practice gidelines for the diagnosis and management of skin and soft-tissue infections[J]. Clin Infect Dis, 2005, 41(10):1373-1406. [3] Breen JO.Skin and soft tissue infections in immunocompetent patients[J]. Am Fam Physician, 2010, 81(7):893-899. [4] May AK.Skin and soft tissue infections: the new surgical infection society guidelines[J]. Surg Infect (Larchmt), 2011, 12(3):179-184. [5] Zervos MJ, Freeman K, Vo L, et al.Epidemiology and outcomes of complicated skin and soft tissue infections in hospitalized patients[J]. J Clin Microbiol, 2012, 50(2):238-245. [6] Dai TH, Tegos GP, Zhiyentayev T, et al.Photodynamic Therapy for Methicillin-Resistant Staphylococcus aureus Infection in a Mouse Skin Abrasion Model[J]. Lasers Surg Med, 2010, 42(1):38-44. [7] Hahn BL, Onunkwo CC, Watts CJ, et al.Systemic dissemination and cutaneous damage in a mouse model of staphylococcal skin infections[J]. Microb Pathog, 2009, 47(1):16-23. [8] Voyich JM, Otto M, Mathema B, et al.Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease[J]? J Infect Dis, 2006, 194(12):1761-1770. [9] Benavides F, Oberyszyn TM, VanBuskirk AM, et al. The hairless mouse in skin research[J]. J Dermatol Sci, 2009, 53(1):10-18. [10] Akiyama H, Huh WK, Yamasaki O, et al.Confocal laser scanning microscopic observation of glycocalyx production by Staphylococcus aureus in mouse skin: does S. aureus generally produce a biofilm on damaged skin[J]? Br J Dermatol, 2002, 147(5):879-885. |